GENOIMMUNE THERAPEUTICS
Genoimmune Therapeutics is a holding subsidiary of Shenzhen Huada Gene Technology Co., Ltd. It is a high-tech biotechnology enterprise dedicated to the treatment of tumor immune cells. Through the use of advanced life digital technology, the human immune system can be fully stimulated against the tumor, and new advanced prevention and treatment programs targeting tumor-specific antigens can be developed to benefit patients. Since 2011, he has focused on the development of tumor genomes, bioinformatics and tumor immunity.
GENOIMMUNE THERAPEUTICS
Industry:
Biotechnology Therapeutics
Founded:
2017-01-01
Address:
Wuhan, Hubei, China
Country:
China
Website Url:
http://www.genoimmune.genomics.cn
Total Employee:
11+
Status:
Closed
Contact:
0755-36352085
Email Addresses:
[email protected]
Total Funding:
120 M CNY
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apple Mobile Web Clips Icon Apache Mobile Non Scaleable Content Apple Mobile Web App Capable Apple Mobile Web App Status Bar Style Java EE Apache Tomcat Coyote
Similar Organizations
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Eureka Therapeutics
Eureka Therapeutics is a biotechnology company focusing on immunotherapies for the treatment of cancer.
Fulcrum Therapeutics
Fulcrum Therapeutics is a biotechnology company that develops new medicines to treat patients with rare genetic diseases.
Innovative Cellular Therapeutics
Innovative Cellular Therapeutics is a Shanghai-based biotechnology company engaged in research and development of cell therapy.
Spero Therapeutics
Spero Therapeutics develops therapeutics for treatment of gram-negative infections.
Current Employees Featured
Founder
Investors List
GF Xinde Investment Management
GF Xinde Investment Management investment in Series A - Genoimmune Therapeutics
Official Site Inspections
http://www.genoimmune.genomics.cn
- Host name: 116.6.107.45
- IP address: 116.6.107.45
- Location: Shenzhen China
- Latitude: 22.5333
- Longitude: 114.1333
- Timezone: Asia/Shanghai
More informations about "Genoimmune Therapeutics"
genoimmune.com - 华大吉诺因生物科技有限公司
武汉华大吉诺因生物科技有限公司为深圳华大基因科技有限公司控股，是一家致力于肿瘤免疫细胞治疗的生物科技企业。我们通过利用先进生命数字化技术，全方位激发人体免疫系统对抗肿瘤 …See details»
Genoimmune Therapeutics - Crunchbase Company …
Genoimmune Therapeutics is a high-tech biotechnology enterprise dedicated …See details»
Corporate Update-BGI Group Official Website - genomics
Jun 28, 2023 Li Bo, CEO of GenoImmune Therapeutics Biotech Ltd., a company within the BGI Group, was recognized in the Clinical Medicine Category. For …See details»
GenoImmune Therapeutics - Products, Competitors, Financials, …
GenoImmune Therapeutics is a biotechnology company specializing in the research and development of immune-oncology therapies. The company focuses on creating personalized …See details»
Genoimmune Therapeutics Co., Ltd. - Drug pipelines, Patents, …
Jun 20, 2025 Explore Genoimmune Therapeutics Co., Ltd. with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, Disease Domain:Neoplasms, Technology …See details»
Shenzhen Genoimmune Medical Institute - szgimi.org
Shenzhen Genoimmune Medical InstituteShenZhen Geno-immune Medical Institute (GIMI) was established in 2015 and funded by the Municipal Government of Shenzhen. GIMI faculty and …See details»
Genoimmune Therapeutics - VentureRadar
"Genoimmune Therapeutics is a high-tech biotechnology company dedicated to tumor immune cell therapy. We use advanced life digital technology to stimulate the human immune system …See details»
Genoimmune Therapeutics Co., Ltd. (武汉华大吉诺因生物科技有限 …
Jun 20, 2025 了解Genoimmune Therapeutics Co., Ltd. (武汉华大吉诺因生物科技有限公司)公司的药物管线，治疗领域，技术平台，以及它的1项临床试, 4篇新闻，疾病领域:肿瘤，技术平 …See details»
GenoImmune Therapeutics - 2025 Company Profile - Tracxn
Mar 8, 2025 Genoimmune Therapeutics is a developer of therapeutic solutions for treating cancer. It has developed Neoantigen based T cell Therapy, cellular immunotherapy that …See details»
Genoimmune Therapeutics - Golden
Genoimmune Therapeutics is a China-based company.Company attributes Location China Total Funding Amount (USD) 17,900,000 Latest Funding Round Date March 20, 2019 Latest …See details»
GenoImmune, a BGI Company, Completes Funding for …
On August 15, 2022 GenoImmune Therapeutics, a Wuhan company founded by China’s gene sequencing company, BGI, reported that it closed a funding round to support its immuno-cell …See details»
Genoimmune Therapeutics (Genoimmune Therapeutics) - 药物管 …
May 7, 2025 了解Genoimmune Therapeutics (Genoimmune Therapeutics)公司的药物管线，治疗领域，技术平台，以及它的6篇新闻。See details»
武汉华大吉诺因生物科技有限公司|武汉市企业服务平台
首页 数据 武汉华大吉诺因生物科技有限公司 武汉华大吉诺因生物科技有限公司 曾用名 { {before.fullname}} 电话：595******** 邮箱： [email protected] 官网： …See details»
科学技术-华大吉诺因生物科技有限公司 - genoimmune.com
MRNA肿瘤疫苗 高通量细胞流式检测平台 先进细胞活性检测方法 GMP无菌/微限实验室 专业高水平质量研究团队See details»
BGI News-BGI Group Official Website - genomics
Apr 6, 2023 Li Bo, CEO of GenoImmune Therapeutics Biotech Ltd., a BGI Group company, was selected for the Clinical Medicine Category. In 2022, BGI researchers’ accomplishments led to …See details»
Corporate Update-BGI Group Official Website - en.genomics.cn
Li Bo, CEO of GenoImmune Therapeutics Biotech Ltd., a BGI Group company, was selected for the Clinical Medicine Category. In 2022, BGI researchers’ accomplishments led to 112 …See details»
BGI’s GenoImmune Raises $18 Million for Neoantigen ... - NAI 500
Mar 20, 2019 GenoImmune, a subsidiary of Shenzhen sequencing company BGI, raised $18 million in an A funding round to support its neoantigen discovery for new immunotherapy …See details»
人才发展-华大吉诺因生物科技有限公司 - genoimmune.com
公司分配的其他任务。 任职资格:1.··· 2021-11-03超级管理员 公司地址 地址：武汉市东湖新技术开发区高新二路388号 深圳吉诺因地址：深圳市盐田区北山道146号 GENOIMMUNE USA INC …See details»
BGI-Backed Chinese Biotech Start-Up GenoImmune Raises $18M …
Mar 20, 2019 Chinese biotech start-up GenoImmune has secured RMB120 million (US$17.87 million) in a series A round of financing led by GF Xinde Investment Management ... BGI, …See details»
Deciphering state-dependent immune features from multi-layer …
8 hours ago A single-cell multiomic immune cell atlas from 235 Japanese, including patients with COVID-19 and healthy individuals, linked with host genetics including germline and somatic …See details»